Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Discover the novel chemical resolution method for c-Met inhibitor PF-2341066. This patent analysis highlights cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN104710509B reveals low-temperature solid-phase synthesis for over 99% purity Eptifibatide, ensuring supply chain stability and reduced impurities for global buyers.
Novel four-step route for Moxifloxacin side chain reduces cost and improves supply chain reliability for global pharmaceutical manufacturing partners.
Patent CN112876524A reveals a scalable, high-yield route for Remdesivir intermediates, offering cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Patent CN101857593A discloses a novel reductive amination route for 9-aminoquinine derivatives, offering high purity and scalable production for pharmaceutical applications.
Advanced synthesis of 3-substituted vinyl cephalosporin derivatives via patent CN1048706A. Enhancing oral antibiotic potency with scalable, high-purity manufacturing processes.
Advanced synthesis patent CN117700405B enables high-purity pharmaceutical intermediates with streamlined processes for cost reduction in API intermediate manufacturing and supply reliability.
Novel 3-step route for Abiraterone Acetate. High purity 98.5%. Scalable process eliminating column chromatography for cost reduction.
Patent CN108658831A reveals high-yield Pd-catalyzed route for Brivaracetam intermediates. Enables cost reduction in API manufacturing and reliable pharmaceutical intermediates supply.
Patent CN1301960C details a novel one-pot hydrogenation method for 2-benzylaniline, offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Novel one-pot synthesis for benzodiazepine intermediates reduces costs and improves purity for midazolam and alprazolam manufacturing supply chains globally.
Patent CN104860870A reveals a safer, ambient-pressure method for producing high-purity piperidine derivatives, offering significant cost and supply chain advantages.
Discover the novel hydroboration-oxidation process for enantiomerically pure 2-(2-arylmorpholin-2-yl)-ethanol derivatives. Enhanced yield and cost efficiency for pharmaceutical manufacturing.
Advanced synthesis of Imipenem monohydrate via phosphorylation and condensation. Reduces impurities and enhances yield for reliable pharmaceutical intermediates supply.
Patent CN101921274A reveals a streamlined Imipenem synthesis using solvent inclusion intermediates, offering significant cost reduction and high-purity manufacturing for pharmaceutical supply chains.
Patent CN1190966A details a streamlined synthesis for HIV protease inhibitor Compound J intermediates, offering significant cost reduction and supply chain reliability for API manufacturing.
Novel process for HMG-CoA inhibitor intermediates offering high stereoselectivity and scalable production for pharmaceutical supply chains.
Patent CN1218463A details novel asymmetric synthesis routes for elastase inhibitor intermediates, offering improved stereoselectivity and scalable manufacturing processes for pharmaceutical supply chains.
Patent CN111116419A details a novel Weinreb amide route for Treprostinil intermediates, offering significant cost reduction and improved supply chain reliability for pharmaceutical manufacturers.
Patent CN109749968A details Bacillus velezensis strain for efficient (R)-1,3-butanediol synthesis. Delivers high purity, mild conditions, and supply chain stability for pharmaceutical manufacturing.